
Varex Imaging Corporation
VREXNASDAQHealthcareMedical - Devices
Previous close
$18.51
+$0.02 · +0.11%
VREX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
65
Undervalued
Momentum
43
Neutral
Sentiment
45
Mixed
Risk resilience
55
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteVarex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Sunny S. Sanyal
- Listed since
- Jan 23, 2017
- Employees
- 2,500
Market position
Day range
Current $18.51
52-week range
Current $18.51
- Open
- $18.485
- Previous close
- $18.49
- Volume
- 953.8K
- 1.45× average
- Average volume
- 655.76K
- Average daily volume
- Market cap
- 779.27M USD
- Beta
- 0.88
- Market reference 1
- 50-day average
- $12.3982
- +49.30% above average
- 200-day average
- $11.9962
- +54.30% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 751.22M USD
- P/E (TTM)
- 35.26×
- P/B (TTM)
- 1.57×
- P/S (TTM)
- 0.9×
- EV / EBITDA
- 214.63×
- Earnings yield
- -14.22%
- Free cash flow yield
- 3.80%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 34.32%
- Operating margin
- 8.35%
- Net margin
- 2.55%
- Return on equity
- -14.88%
- Return on assets
- -6.35%
- Return on invested capital
- -3.00%
Financial health
- Debt / equity
- 0.75×
- Current ratio
- 3.43×
- Altman Z-score
- 2.27
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 844.6M USD | 811M USD | 893.4M USD | 859.4M USD | 818.1M USD |
| Cost of goods sold | 554.1M USD | 554.1M USD | 603.1M USD | 575.9M USD | 546.6M USD |
| Gross profit | 290.5M USD | 256.9M USD | 290.3M USD | 283.5M USD | 271.5M USD |
| Research and development | 91.1M USD | 87M USD | 84.8M USD | 77M USD | 71.9M USD |
| Selling, general, and administrative | 133.3M USD | 137.8M USD | 128.4M USD | 118.3M USD | 125.5M USD |
| Operating expenses | 318.3M USD | 224.8M USD | 213.2M USD | 195.3M USD | 197.4M USD |
| Interest income | 8.5M USD | 7.3M USD | 3.7M USD | 400K USD | 100K USD |
| Interest expense | 35.5M USD | 31.1M USD | 29.3M USD | 41M USD | 43.4M USD |
| Depreciation and amortization | 27.2M USD | 31.1M USD | 33.2M USD | 33.6M USD | 37.3M USD |
| Operating income | −27.8M USD | 32.1M USD | 77.1M USD | 88.2M USD | 74.1M USD |
| Net income | −70.3M USD | −47.7M USD | 47.4M USD | 30.3M USD | 17.4M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 64%
- 7 beats, 4 misses, 0 met estimates
- Average EPS surprise
- +63.99%
- 11 comparable reports
- Latest EPS result
- 0.31
- Estimate 0.21 · Beat by 47.55%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$14.50
21.66% downsideRating distribution
7 ratingsRecent analyst actions
VREX news
VREX peers
ETFs holding VREX
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM19.95M0.02%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI15.05M0.00%2.3T USD0.03%$378.24+0.44%
Fidelity Enhanced Small Cap ETFFESM7.84M0.12%6.03B USD0.28%$47.94+0.80%
iShares Russell 2000 Value ETFIWN7.38M0.05%14.66B USD0.24%$224.81+0.45%
Vanguard Extended Market ETFVXF5.38M0.01%93.7B USD0.05%$245.53+0.82%
Schwab Fundamental U.S. Small Company Index ETFFNDA4.41M0.05%9.26B USD0.25%$37.73+0.75%
iShares U.S. Medical Devices ETFIHI3.7M0.11%3.49B USD0.37%$56.17+1.30%
Schwab U.S. Small-Cap ETFSCHA3.63M0.02%23.1B USD0.03%$34.83+0.52%
iShares Russell 2000 ETFIWM- Market value
- 19.95M
- Weight
- 0.02%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 15.05M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Fidelity Enhanced Small Cap ETFFESM- Market value
- 7.84M
- Weight
- 0.12%
- AUM
- 6.03B USD
- Expense ratio
- 0.28%
- Price / 1D
- $47.94+0.80%
iShares Russell 2000 Value ETFIWN- Market value
- 7.38M
- Weight
- 0.05%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Vanguard Extended Market ETFVXF- Market value
- 5.38M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
Schwab Fundamental U.S. Small Company Index ETFFNDA- Market value
- 4.41M
- Weight
- 0.05%
- AUM
- 9.26B USD
- Expense ratio
- 0.25%
- Price / 1D
- $37.73+0.75%
iShares U.S. Medical Devices ETFIHI- Market value
- 3.7M
- Weight
- 0.11%
- AUM
- 3.49B USD
- Expense ratio
- 0.37%
- Price / 1D
- $56.17+1.30%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 3.63M
- Weight
- 0.02%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
Continue in GoAI
Research VREXresearch.disclaimer











